Abstract:Background Detection of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) relies on real-time-reverse-transcriptase polymerase chain reaction (RT-PCR) on nasopharyngeal swabs. The false-negative rate of RT-PCR can be high when viral burden and infection is localized distally in the lower airways and lung parenchyma. An alternate safe, simple and accessible method for sampling the lower airways is needed to aid in the early and rapid diagnosis of COVID-19 pneumonia. Methods In a prospective unblinded observational study, patients admitted with a positive RT-PCR and symptoms of SARS-CoV-2 infection were enrolled from three hospitals in Ontario, Canada. Healthy individuals or hospitalized patients with negative RT-PCR and without respiratory symptoms were enrolled into the control group. Breath samples were collected and analyzed by laser absorption spectroscopy (LAS) for volatile organic compounds (VOC) and classified by machine learning (ML) approaches to identify unique LAS-spectra patterns (breathprints) for SARS-CoV-2. Findings Of the 135 patients enrolled, 115 patients provided analyzable breath samples. Using LAS-breathprints to train ML classifier models resulted in an accuracy of 72·2-81·7% in differentiating between SARS-CoV2 positive and negative groups. The performance was consistent across subgroups of different age, sex, BMI, SARS-CoV-2 variants, time of disease onset and oxygen requirement. The overall performance was higher than compared to VOC-trained classifier model, which had an accuracy of 63-74·7%. Conclusion This study demonstrates that a ML-based breathprint model using LAS analysis of exhaled breath may be a valuable non-invasive method for studying the lower airways and detecting SARS-CoV-2 and other respiratory pathogens. The technology and the ML approach can be easily deployed in any settting with minimal training. This will greatly improve access and scalability to meet surge capacity; allow early and rapid detection to inform therapy; and offers great versatility in developing new classifier models quickly for future outbreaks.

Machine Learning Approaches: Detecting the Disease Variants in Human-Exhaled Breath Biomarkers

Prediction of Pulmonary Diseases With Electronic Nose Using SVM and XGBoost

Breath VOC analysis and machine learning approaches for disease screening: a review

A Spiking Neural Network-based Olfactory Bionic Model for Periodontal Diseases Screening by Exhaled Breath with Electronic Nose

Breath Analysis for Detecting Diseases on Respiratory, Metabolic and Digestive System

Research on Hybrid Recognition Algorithms of Lung Cancer Breath Diagnosis Based on MOS and SAW Sensors

Low-Cost Lung Cancer Detection Using Machine Learning on Breath Samples

Prediction of lung cancer with a sensor array based e-nose system using machine learning methods

Smelling the Disease: Diagnostic Potential of Breath Analysis

Detection of lung cancer and stages via breath analysis using a self-made electronic nose device

Fast and automated biomarker detection in breath samples with machine learning

Noninvasive Diabetes Detection through Human Breath Using TinyML-Powered E-Nose

Breath analysis for the screening and diagnosis of diseases

Recent Trends in Exhaled Breath Diagnosis Using an Artificial Olfactory System

Nanomaterial-Based Sensors for Exhaled Breath Analysis: A Review

Machine learning enabled detection of COVID-19 pneumonia using exhaled breath analysis: a proof-of-concept study.

Volatile Organic Compounds as Potential Biomarkers for Noninvasive Disease Detection by Nanosensors: A Comprehensive Review

Research progress of electronic nose technology in exhaled breath disease analysis

Artificial Intelligence Based Breath Analysis System for the Diagnosis of lung cancer

Breath Analysis as a Potential and Non-Invasive Frontier in Disease Diagnosis: An Overview

Respiratory Diseases Detection using Machine Learning